Dr. Ernesto J. Ayala-cruz, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: #1462 Steer Prof.augusto Rodriguez, Toa Altasan Juan, PR 00910 Phone: 787-799-1558 Fax: 787-799-1558 |
News Archive
Nevro Corp., a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the first commercial case has been performed in the United States under the company's May 8th, 2015 FDA approval for commercial use of the Senza spinal cord stimulation (SCS) system, which delivers Nevro's proprietary HF10 therapy.
DestinationRx, a leading provider of Medicare plan and drug comparison tools, today announced the results of a DestinationRx analysis showing a significant increase in consumers choosing to enroll in health plans online, coupled with a parallel decrease in call center enrollments. An analysis of DestinationRx commercial enrollments shows a 12 percent shift from call center to online enrollment for 2008 to 2009 and an 11 percent shift from 2009 to 2010, for a 23 percent total increase in online enrollments over just two years.
The American Psychological Association condemned the administration's efforts to use federal rules to dismantle civil rights protections in health care for vulnerable populations, particularly transgender and gender non-conforming patients.
The Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital will host a public forum and scientific workshop Oct. 14 to 16 to discuss emerging issues of importance for the National Institutes of Health (NIH) for women's health research in the coming decade.
pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the Italian Medicines Agency (Agenzia Italiana del Farmaco) has granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
› Verified 1 days ago